Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bioatla Inc (BCAB)

Bioatla Inc (BCAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bioatla Inc 11085 TORREYANA ROAD SAN DIEGO CA 92121 USA

www.bioatla.com Employees: 61 P: 858-558-0708 F: 858-558-0709

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

BioAtla Inc. is a clinical-stage biopharmaceutical company. It engages in developing a novel class of antibody-based therapeutics for the treatment of solid tumor cancer. BioAtla Inc. is based in SAN DIEGO.

Key Statistics

Overview:

Market Capitalization, $K 10,814
Enterprise Value, $K -38,236
Shares Outstanding, K 63,464
Float, K 55,994
% Float 88.23%
Short Interest, K 6,613
Short Float 10.42%
Days to Cover 2.60
Short Volume Ratio 0.31
% of Insider Shareholders 11.77%
% of Institutional Shareholders 77.23%

Financials:

Annual Sales, $ 11,000 K
Annual Net Income, $ -69,780 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -15,780 K
EBIT, $ -66,290 K
EBITDA, $ -65,360 K

Growth:

1-Year Return -62.02%
3-Year Return -94.06%
5-Year Return -99.68%
5-Year Revenue Growth 111.54%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.27 on 11/13/25
Next Earnings Date 03/26/26
Earnings Per Share ttm -1.19
EPS Growth vs. Prev Qtr 12.90%
EPS Growth vs. Prev Year -22.73%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

BCAB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -200.67%
Profit Margin % -634.36%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.53
Interest Coverage -2.19
60-Month Beta 1.10
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar